Showing posts with label anal cancer. Show all posts
Showing posts with label anal cancer. Show all posts

Sunday, December 30, 2012

The BEST of Lifelube - "Hey! Keep Your Booty Healthy and Happy with Regular Pap Smears" From Tuesday, December 28, 2010


Hey! Keep Your Booty Healthy and Happy with Regular Pap Smears



via AlterNet, by Antoine B. Craigwell


While anal cancer isn’t that common it’s preventable. But you can only prevent anal cancer if you know you have HPV, are screened and have the precancerous areas treated. You can only do this if you live in an area where anal-pap-smear testing is available and resources exist to provide preventive follow-up.

Early one fall morning, 26-year-old Mark Ramos (not his real name) walked into the New York-based Callen-Lorde Community Health Center for a routine medical check up. After several questions about his sexual practices, Mark consented to a rectal exam. He dropped his pants and underwear and climbed up on to the exam table in a kneeling position. The doctor cautioned that he would feel a slight discomfort as he swabbed Mark’s anus and took the male equivalent of a pap smear. Two weeks later, Mark received a call and was advised that the pap smear revealed that there was a suggestion of the presence of abnormal cells and was invited to come in for a colposcopy, a more thorough examination; the male equivalent of a cervical exam.

Except for that heightened fashion sense, creativity, artistry, and culinary skills, men who have sex with men (MSM) do have at least one thing in common with women: one of the effects of the human papilloma virus (HPV) which causes cervical cancer in women and anal cancer in MSM. Over the years knowledge and treatment for this virus has gradually “come out” of the classification as a women only problem, where more and more MSM are receiving examinations, screenings, and treatment, if precancerous cells are discovered. Anal cancer came to prominence recently with the death of Farah Fawcett.

Read the rest.


Also of butt health interest:

HPV
Yes, I’m Talking to You! A Conspiracy of Silence about Gay Men’s Anal Health 
via White Crane Journal, by Jeff Huyett

Anal Cancer Info, via UCSF Department of Medicine

Friday, November 11, 2011

Getting to the Bottom of It

via PostivelyAware, by Gary Bucher

Gary Bucher, MD, FAAFP is a leading anal dysplasia and anal cancer prevention specialist in the U.S. Dr. Bucher is certified in performing high resolution anoscopy for the evaluation and treatment of anal pre-cancerous lesions. He is the founder and medical director of Anal Dysplasia Clinic MidWest with locations in Chicago and St. Louis, and is involved in clinical trials in the field. 

Gary was one of LifeLube's distinguished speakers at Project CRYSP's last community forum for the year "Get Freaky" hear the podcast here Courtesy of Feast of Fun!

I have witnessed and taken part in the many changes in HIV care over the past 25 years. At the beginning of the epidemic, silence and fear was the name of the game.

It took HIV activists taking control of their health care destiny to force the medical community to treat the disease and the patient.

HIV is now a chronic treatable disease, but it has a whole new set of issues regarding conditions related to prematu cian should feel for any tender areas, thickened lesions, shallow indentations, firm masses, or other abnormalities.

I also ask the patient if they have performed an anal self-exam by using their finger to feel around for any lumps or bumps inside their anus. This can help guide me when I perform the digital anorectal exam.

Anal Pap smears are performed in a similar fashion to cervical Pap smears, with the area being swabbed to collect cells, which are then examined under a microscope.

They can detect abnormal cells (anal dysplasia), but the anal Pap smear may be less likely to correlate with the degree of anal dysplasia that can be seen on a biopsy of an anal lesion revealed by high resolution anoscopy (HRA).

 Because such specificity is lacking, and there haven’t been any evidence-based clinical trials to evaluate anal cancer screening methods in preventing anal cancer, many clinicians feel that anal Pap smears should not be done at this time. However, I agree with other experts in the field who have proposed yearly anal Pap smears for all HIV-positive individuals.

If the anal Pap is normal, continued annual screening is suggested. Experts also recommend anal Pap smears every one to two years for other high-risk groups and if normal, continued screening every two or three years. If any abnormal cells are detected, HRA with biopsy is recommended.

However, these guidelines may be limited by the need to train a greater number of clinicians in performing HRAs and biopsies. It is also important for these screening tests to be administered in a non-hospital setting, to maximize patient compliance with screening and follow-up.

High-risk HPV subtypes, especially 16 and 18, are associated with cervical, anal, penile, vulvar, vaginal, and oral cancers. Cervical cancer is an AIDS-defining malignancy and its incidence has been decreasing with aggressive screening and treatment of pre-cancerous lesions or higher grade cervical dysplasia.

Cervical cancer affected 35-40 per 100,000 women in the general population prior to cervical cancer screening and treatment and has now decreased to about 8-10 per 100,000.

Though most genital and oral cancers are caused by high risk HPV, these cancers are not increasing as fast as anal cancer in HIV-positive individuals and other high-risk groups.

Compared to the more common lung cancer, penile, vaginal, and vulvar cancers are rare—between 0.42 and 1.8 per 100,000. Oral cancer affects an average of six men and 1.76 women per 100,000.

Anal cancer in the general population is still very rare and affects more women than men. The incidence in men is 1.14/100,000 compared to 1.76/100,000 in women.

Individuals at increased risk for developing anal cancer include HIV-positive men and women; HIV-negative men who have sex with men (MSM); women with a history of cervical, vaginal, or vulvar cancer or cervical dysplasia; chronically immunosuppressed organ transplant patients; men and women with a history of anal warts; and people who smoke tobacco.



 

Friday, October 28, 2011

HPV is a Gay Men's Health Crisis


A committee from the Centers for Disease Control and Prevention recently made headlines by recommending human papillomavirus (HPV) vaccinations for boys and young men.

Previously, vaccination, which also protects women from cervical and other cancers, was recommended for girls only.

I commend the committee’s decision: Vaccination can all but eliminate HPV-related cancers. Almost all instances of anal cancer are caused by HPV, which is sexually transmitted.

HPV also causes many oral and other so-called head and neck cancers.

HPV is a gay men’s health issue. Anal cancer affects about two in 100,000 people in the U.S., but the rate of anal cancer among gay and bisexual men is as much as 44 times higher.

 Although vaccination is an important step, this recommendation is not enough. Prejudice and stigma continue to hinder an adequate public health response to HPV.

 As with HIV/AIDS, for HPV and anal cancer silence equals death.

Even though the HPV vaccine, called Gardasil or Silgard, was approved and recommended for use in girls since 2006, it has been hard to get girls vaccinated.

The exchange about HPV in a recent debate among Republican presidential contenders sheds light on Americans’ reluctance:

As former senator Rick Santorum charged, “this disease is spread through sexual contact... unless 11- and 12-year-olds in the state of Texas are somehow encouraged to participate in that activity, this is not something that the state or federal government should be doing.”

The argument is that vaccinating girls encourages them to engage in sex. This is a ludicrous suggestion because Gardasil protects against infection at any time over a lifetime — it is not specific to sex in youth.

Other arguments — concerning the safety of the vaccine, for example — have been repudiated repeatedly by medical authorities.

If it has been so hard to get girls vaccinated, for fear of encouraging heterosexual sex, it is no surprise that public health authorities in the U.S. have been reluctant to recommend HPV vaccination to protect boys who, when they become sexually active, may engage in same-sex anal sex.


Read the rest

Friday, August 26, 2011

Duh, it’s HPV too

via Gay City News, by Perry N Halkitis, Ph.D., M.S. with Jaclyn Blachman-Forshay

Last year, the New York City Department of Health and Mental Hygiene (NYCDOHMH) terrorized us with their prevention campaign “It’s Never Just HIV.” My colleagues at Gay Men’s Health Crisis, who recognized the inflammatory nature of this prevention effort, held a community forum where leaders of the health department argued their perspectives — while many members of the community expressed their outrage.

In this HIV public service announcement, we were warned about many complications of HIV infection — including the increased risk for anal cancer among gay HIV-positive men (a fact that medical science supports). It was not the message with which we took issue, but the manner in which the message was portrayed. Recall the television ad! It was a graphic image of a luminescent, radioactive ass that scared the heck out of ALL gay men. For me personally, it made my annual anal Pap smear an event of great anxiety, one that I considered canceling at least a dozen times.

Many of us know that genital human papilloma virus (HPV), of which there are more than 40 types, is the pathogen that can cause anal or genital warts (HPV types 6 and 11 may cause warts). What is less known, however, is that there are certain types of HPV (such as HPV types 16 and 18) which can serve as the causes of anal cancer. National and local health efforts have been undertaken to educate the population about the link between HPV and cervical cancer in women. However, associations between HPV and anal cancer — which as we know may affect more than gay men — remain few and far between. There are clearly articulated policies for women’s health, including recommended immunizations against HPV for women and young girls as described in the city’s health bulletin urging vaccination (Volume 7, Number 1). For men, particularly gay men who may be most at risk for contracting a form of HPV that may cause anal cancer, the recommendations are less clear and definitive. In fact, this message is all but absent.

While the NYCDOHMH guidelines recommend anal Pap smears for HIV-positive men on a routine basis, the NYCDOHMH Sexually Transmitted Infections (STI)Screening Guidelines for Sexually Active Patients lists the Pap as “N/A” (not applicable) for other men who have sex with men (MSM). Although the risk for anal cancer may be less for HIV-negative men, one still is left to wonder how a health commission — focused on warning about the dangers of anal cancer in their HIV prevention campaign — is somewhat aloof and silent in its recommendations for gay men regarding HPV (both in terms of screening for anal cancer and routine vaccination of young men and boys before they become sexually active).

To make matters worse, some doctors treating HIV-positive gay men also do not routinely undertake Pap smears of their patients. According to Dr. Stephen Goldstone of Mount Sinai Hospital in New York City, author of “The Ins and Outs of Gay Sex: A Medical Handbook for Men” and one of the world’s leading authorities on anal cancer in gay men, “There is a real embarrassment on the part of both patients and healthcare providers to deal with sexual health issues and anal health issues. Most patients don’t even get a rectal exam let alone an anal Pap smear. It is unfortunate that many anal cancers I see are quite large and would have been picked up much sooner had the patient just had a rectal exam.”


Read the rest.

Tuesday, April 26, 2011

Andrew's Anus and the Quest [yes, he's back with Part 7!]

[Check out the hole series.]

For 20 years, Andrew thought of the warts that occasionally sprang up on me as well . . . just warts.

I’m Andrew’s Anus, and I have HPV.

Eventually Andy realized that the human papillomavirus could lead to dysplasia and even anal cancer.

Andy had a good deal of confidence in his HIV providers, but his quest to find better care for me and my HPV uncovered a sad truth about living in the U.S.: 
The best anorectal HPV care is available only in a relatively small number of large cities in a minority of states, and the clinics that offer it don’t have the capacity to treat everyone who needs their services.
Getting a high resolution anoscopy (HRA) in just such a clinic had become a priority for Andrew. He’d had three surgeries to remove HPV-related growths and lab testing had twice indicated middle grade dysplasia. Meanwhile, he kept hearing that cancers not historically considered AIDS-related were being observed more frequently in HIV patients. The point was brought home when Andy was diagnosed with a basal cell carcinoma on his left shin. It was treated successfully, and he realized there wasn’t necessarily a direct connection, but all the same . . .

Andy began to email advocates he’d met over the years for advice and referrals. A friend responded with a website that listed providers trained by one of the best anal cancer research centers in the country. The first, most obvious candidatewas inthe larger metropolitan area closest to home. Unfortunately,only PLWHA who were already patients in the local Ryan White clinic could be seen there.

Andy kept looking.

A pozcouple he’d mentored when they were newly diagnosed tried to help. Andy pestered them to find out who their HIV doctor recommended. The doc couldn’t think of anyone in the city doing HRAs, but his nurse did give the name of a reputable specialist in town. Things began to look brighter when Andy called there. “Yes we see lots of HIV positive patients,” the person on the other end of the phone responded. “Yes we do high resolution anoscopies here. Yes we accept that insurance.”

The next day Andy got a call from the medical director who apologized that there had been a misunderstanding. The practice did not perform high resolution anoscopies. The doctor was polite and curious; Andy was put in the awkward position of explaining to a big city colorectal surgeon that HRA was considered by many to be a critical tool in preventing anal cancer. “That requires a very expensive piece of equipment,” she quipped. “No, I don’t know of anyone performing HRAs in this area.”

Andy’s frustration began to edge over into anger territory. 

When he attended a town hall meeting organized by a national advocacy organization as part of a regional PLWHA conference, the chair of the U.S. Presidential Advisory Council on HIV/AIDS (PACHA) asked the audience to talk freely about their concerns.

Andy stood up and asked,

“What are you going to do about the massive anorectal neglect that’s occurring in this country?" 

"Rectal microbicide research is a decade behind vaginal research," he continued, "and most people who need access to screening and treatment for anal dysplasia and cancers can’t get it!” The chair agreed the issue was important and said that part of the solution was for people like Andy “to keep advocating.”

Andy picked up a new leadwhen he ran into a mentor at a fall 2009 LGBT health conference. Two researchers who were presenting at the conference were at the table. The four of them were catching up on gossip when Andy off-handedly mentioned how little luck he’d had trying to get an HRA. To his surprise, one of the presenters turned, looked Andy in the eye, and said, “I’ll do that for you.”

Although he’d known that Dr. Langston was a researcher in the field of HIV prevention, it was news to him that he also ran an anal dysplasia clinic.The hospital that housed the clinic was a 600 mile drive from home. Still, there was a chance Andy might earn a scholarship to an upcoming conference there, and he could see Dr. L. then. When that didn’t happen, he set aside the option as too expensive.

Discouraged, Andy dropped his search and the months flew by. Suddenly, he realized it had been nearly a year since his last surgery and resumed his quest in earnest. He looked up the manufacturer of a device used to treat anal dysplasia using infrared coagulation (IRC). Maybe they could help him find a clinic. The sales rep who finally called back suggested one that was eight hours’ drive away – not too promising. He also shared the phone number for a Ryan White grants manager in an adjacent state who’d just bought a unit for a new project. Unfortunately, Andy’s calls there were not returned.

Later that year, at the 2010 Gay Men’s Health Summit, he attended a session on HPV and once again spoke out. Responding to the presenter’s prescription for anal Pap smears, HRA, and treatment, Andy asked whether the speaker realized that most peoplehad no access to these things. Further, did the presenter realize that leading researchers had gone on record saying that providing anal Pap smears was unethical unless a system of follow up screening and care was in place? What were people to do?

One trusted researcher who happened to be in the audience suggested that perhaps a charge of malpractice should be made, but when pressed he admitted that it probably wouldn’t be a practical course of action. Andy recognized the PACHA chair in the audience and approached him with questions. Andy figured a number of HIV clinics already owned the equipment necessary to provide HRAs and were using them for colposcopies to reduce cervical cancer risk in women. Had they been bought with federal funds?

Could that fact somehow be leveraged to apply pressure or attract funding where it was needed?

Tired of investing his energy in what felt like a wild goose chase, Andy decided it was time for action.He was convinced that it was critical for me to have an HRA, to at least establish a baseline, regardless of the cost.When he got home from the conference, he emailed Dr. Langston to ask if his offer was still good, and got an affirmative (and affirming) response.

And cost him it would. Andy thought making a road trip out of the journey could be fun, but when he did the math he nixed the idea.Years of living with HIV had affected his energy level. That would mean extra motel nights. Counting that, the time away, and the gas plus wear and tear on his car, flying came in at about the same cost – almost half of his monthly income.

Andy logged onto a travel website and began making arrangements for his first high resolution anoscopy.


(to be continued... stay tuned)


Read previous installments.


As told to Mark Hubbard

Friday, April 8, 2011

VIDEO: Doctor Ho and Andrew's Anus

via Pittsburgh's Positive OUTLook

Learn more about anal health from a hot doc and a sexy advocate.


Isn't Dr. Ho DREAMY??? Please sir, may we have another pap smear?

And of course, we LOVE our very own Mark Hubbard, the genius behind Andrew's Anus :) Make sure you check out the hole Andrew's Anus series, a first-booty perspective on anal health - there have been six installments so far, and more to come.


Tuesday, March 22, 2011

Andrew's Anus in the 21st Century [exclusively on LifeLube - Part 6]

[Check out the hole series.]

The human papillomavirus in me laid low and kept quiet for many years. When the big odometer in the sky rolled over from 1999 to 2000, Andrew began to re-think his priorities. He wanted to continue helping folks like himself and decided that meant learning more about the viruses he carried.

Little did we know that before the decade was done, I’d have to go back under the knife.

It was early in the new millennium when Andy first heard someone suggest that HIV positive men needed to get anal Pap smears. He thought that sounded pretty strange, and when he asked local doctors about it the response was dismissive.

“It’s an interesting idea,” one told him, “but what do we do with the information once we have it? There’s no standard to tell us how to proceed.”

When his birthday rolled around, Andy decided to have a Mardi Gras-themed party to celebrate that he was healthy and had made it to his 40th. When he’d gotten his HIV diagnosis at 25, he hadn’t even expected to live to see 30. The cover of the invitation was a picture of a boy sitting on a stoop “flipping off” the world. Inside, Andy invited his friends to come help him “give the virus the finger.”

They decorated his condo complex’s clubhouse in purple, green, and gold and served muffulettas and king cake. The stereo blasted “Lady Marmalade” and “Diamonds are a Girl’s Best Friend” from the Moulin Rouge soundtrack. Andy was single at the time, but one of his straight friends made a pointed remark about the number of his ex-lovers there. “Yes, I’m lucky,” Andy replied, “although it has sometimes taken time, I’ve managed to stay friendly with most of them.”

Speaking of giving the finger, both Andy and his doctor had grown complacent about examining me. 

On the rare occasions that Andy did check, he’d only felt what he assumed were small hemorrhoids. These came and went over the years and he didn’t think he needed to be concerned.

One July day, out of the blue, Andy’s doctor did give him a digital rectal exam (or DRE) and discovered what he called a polyp.Andy wondered if he should be concerned. “I’m not really sure what it is,” the doctor said. He referred Andy to a practice that handled lots of miscellaneous surgeries for local HIV patients.

Dr. Graves mainly treated cancer patients but he was committed to helping the HIV community.In terms of bedside manner he was a dream. He examined me with a simple, clear device called an anoscope, and took the time to explain everything before he did it, while he was doing it, and after he’d done it. Dr. G.said the polyp was likely HPV-related and should be removed with outpatient surgery and sent for testing.

The hospital experience was uneventful in a good way. Andy was in and out without complications. After he woke up, Dr. G came by to tell Andy that things had gone well. “You do have a hemorrhoid,” he told Andy, “and we have a good way of handling those when necessary, but we left it alone.”

When Andy went to Dr. Graves’ office for the follow up visit, Dr. G explained that the pathology did report abnormal cell growth also known as dysplasia. “We think of this in terms of three levels,” he said, “ranging from the mildest to what could be called pre-cancerous.”

“Yours is in the middle range,” he added.“You don’t need to be too concerned, but we do need to keep an eye out for any future developments.”

Andy had begun to go to a few community meetings on HIV/AIDS and gay men’s health. He started to hear HPV and anal dysplasia discussed from an activist point of view. Although his latest experience had for the first time helped him to understand that there could be a connection between HPV and anal cancer, he didn’t really think about it much.

Those concerned included gay men working in big city clinics doing treatment and research in the field. More HPV-related lesions with abnormal or pre-cancerous cells were being seen, they said, and the trend was particularly pronounced in HIV positive gay and bi men. They wondered out loud if a future cancer epidemic was smoldering beneath the surface.

While there wasn’t universal agreement, these researchers and practitioners had observed that when patients were screened regularly and the highest grade lesions removed, anal cancer only rarely occurred and so might be prevented.

Experts said the best method for screening was something called a high resolution anoscopy, or HRA. Andy learned that the procedure was very similar to one called a colposcopy during which women with abnormal Pap smears have their vagina and cervix examined. Trained doctors or nurses use special equipment (a stereoscopic scope and/or a digital camera)along with vinegar and iodine solutions to more reliably identify lesions that need to be biopsied. Andy asked around, and while colposcopies were being provided in local HIV clinics, no one in his region (or even in his state) was providing the rectal version.

Andy had occasionally noticed tiny blood spots on the Charmin after a bowel movement. When the heat and humidity of July returned, it occurred to him that his regular HIV doctor hadn’t asked about or examined me in a year. He hadn’t seen Dr. Graves since just after his last surgery. It was high time Andy scheduled an appointment. I’m sure glad he did.

Dr. G found a new lesion. “It’s a small growth on a hemorrhoid” he said. “I think I can remove it surgically here and now, if that’s alright with you.” For just a moment, Andy flashed back twenty years to his experience with the quack. Dr. Graves had earned his trust, though, and Andy told him, “Sure - let’s take care of it.”

True to form, Dr. G. explained everything and was exceedingly gentle. He used a local anesthetic, and with his nurse’s assistance began the procedure. “I think I need to put just one stitch in here to minimize any bleeding, OK Andy?” he asked. It was, of course. “I think I got it all,” he said afterward, “but from its looks I suspect that it is of a type that might grow back.”

Dr. Graves explained that he would send the tissue out for testing. When Andy next heard from the surgeon, he learned that the results once again showed cells with that middle grade of dysplasia.

Living with HIV for decades had taught Andy that some amount of what others might call denial could be useful. In the early years, everyone had – and rightfully so – been paranoid about any little symptom. Over time they’d learned to distinguish between minor and serious problems and to know when they did and did not need to call the doctor.

It was time for Andy to lift the veil of denial he’d held between himself and me regarding HPV. Fortunately he realized it.

I was at risk for high grade dysplasia or even cancer, and common sense told Andy that the care he was getting for me was just not good enough.

(to be continued... stay tuned)


Read previous installments.


As told to Mark Hubbard

Thursday, January 6, 2011

HPV Vaccine Approved to Prevent Anal Cancer

via About.com, by Mark Cichocki, R.N.

Gardasil, the HPV vaccine approved for the prevention of HPV related cervical cancer has now been approved by the Food and Drug Administration (FDA) to be used to prevent anal cancer in people age 9 to 26 years.

Many people believe anal cancer is only a problem in gay men due to anal sex.

However, women can get HPV related anal cancer as well. [LifeLube note - women have anal sex too, hon. It is not uncommon.]

In fact, the American Cancer Society estimates that there are 5300 new cases of anal cancer each year with more women being diagnosed than men. Anal cancer is still uncommon in the general population but the incidence is on the rise with 90% of cases being related to HPV. Experts note that Gardasil will not impact precancerous lesions already present at the time of vaccination. Also, for the maximum affect of Gardasil, people should be vaccinated prior to exposure to HPV; or simply put prior to becoming sexually active.

Click for links to more info on HPV, anal paps and Gardasil.

Click here for more LifeLube links on the topic of anal health.

Click here for the Gay Men's Health Crisis press release on Gardasil for men.

Wednesday, January 5, 2011

'It's Never Just HIV' Ad Campaign Oversimplifies the Issue - Sean Strub on HuffPo

via Huffington Post, by Sean Strub

If the NYC Department of Health pursued a campaign to combat transmission of HPV, does anyone think they would, for a moment, consider using a close-up image of a horribly diseased vagina? 
Excerpt 1:



I think this advertising campaign is terrible, mostly because it may contribute to further spread of the virus. The only good it has accomplished is that it has provided a brief moment when a few more people are thinking about and paying attention to HIV-prevention issues. That is an opportunity that I hope we will not waste.

Supporters of these ads claim HIV prevention has been a failure, and they are angry that the epidemic has disappeared from the media and fallen off the list of priorities for LGBT organizations and others who once were leaders in the fight against AIDS.

I share that anger. It is profoundly frustrating, disempowering and, quite frankly, depressing to see so many one-time activists, caring friends and neighbors, concerned journalists, political and public policy leaders disappear like a puff of smoke once combination therapy brought a relative cure to those with the privilege of healthcare access.

Excerpt 2:

In 1983, very early in the epidemic, Joseph Sonnabend, MD, famously and courageously said, "the rectum is a sexual organ and it deserves the respect a penis gets and a vagina gets." Eric Rofes, Walt Odets and other pioneering thinkers about gay male health and sexuality have subsequently explored similar themes.

I couldn't help but think of this when I saw the close-up image of a man's anus, covered in cancerous lesions, in the NYC DOH ad. Anal cancers are preceded by genital warts, which are caused by strains of HPV, the Human Papiloma Virus. Last year, 4,000 women in the U.S. died of cervical cancer; in virtually every case the cancer was caused by HPV.

If the NYC Department of Health pursued a campaign to combat transmission of HPV, does anyone think they would, for a moment, consider using a close-up image of a horribly diseased vagina?

The bodies and sexuality of gay and bisexual men are seen as dangerous and our sexuality as threatening. We are so little respected that it is acceptable to show an exceptionally intimate part of a gay man's body, one visibly riddled with cancerous lesions, and put it on television as a tool to frighten us.
Read the rest.

Tuesday, December 28, 2010

Hey! Keep Your Booty Healthy and Happy with Regular Pap Smears


via AlterNet, by Antoine B. Craigwell


While anal cancer isn’t that common it’s preventable. But you can only prevent anal cancer if you know you have HPV, are screened and have the precancerous areas treated. You can only do this if you live in an area where anal-pap-smear testing is available and resources exist to provide preventive follow-up.

Early one fall morning, 26-year-old Mark Ramos (not his real name) walked into the New York-based Callen-Lorde Community Health Center for a routine medical check up. After several questions about his sexual practices, Mark consented to a rectal exam. He dropped his pants and underwear and climbed up on to the exam table in a kneeling position. The doctor cautioned that he would feel a slight discomfort as he swabbed Mark’s anus and took the male equivalent of a pap smear. Two weeks later, Mark received a call and was advised that the pap smear revealed that there was a suggestion of the presence of abnormal cells and was invited to come in for a colposcopy, a more thorough examination; the male equivalent of a cervical exam.

Except for that heightened fashion sense, creativity, artistry, and culinary skills, men who have sex with men (MSM) do have at least one thing in common with women: one of the effects of the human papilloma virus (HPV) which causes cervical cancer in women and anal cancer in MSM. Over the years knowledge and treatment for this virus has gradually “come out” of the classification as a women only problem, where more and more MSM are receiving examinations, screenings, and treatment, if precancerous cells are discovered. Anal cancer came to prominence recently with the death of Farah Fawcett.

Read the rest.


Also of butt health interest:

HPV
Yes, I’m Talking to You! A Conspiracy of Silence about Gay Men’s Anal Health 
via White Crane Journal, by Jeff Huyett

Anal Cancer Info, via UCSF Department of Medicine

Wednesday, November 3, 2010

Study: HPV Vaccine Cost Effective for Gay Men

via Medical News, by Nancy Walsh

Vaccinating men who have sex with men (MSM) against human papillomavirus (HPV) may be a cost-effective approach to the prevention of anal cancer and genital warts, according to a study using decision-analysis models.

Read the rest.

Thursday, September 9, 2010

Imiquimod (Aldara): good treatment for pre-cancerous anal lesions in poz men

via Aidsmap, by Michael Carter

HIV treatment centres should screen and treat pre-cancerous anal lesions, UK investigators argue in the online edition of AIDS. They were prompted to make this suggestion by research showing that treatment with imiquimod cream resolved or downgraded high-grade pre-cancerous anal lesions in 61% of HIV-positive gay men.

Although the investigators do not claim that imiquimod will prevent anal cancer, “we at least know that high grade anal intraepithelial neoplasia [HG-AIN, pre-cancerous lesions] can be cured. This is certainly not going to prevent all anal cancers, but it would be a grave error to await the outcome of long-term natural history studies…the time has come for all HIV centres to begin screening for and treating AIN.”

Rates of anal cancer are increasing in patients with HIV. Before the cancer develops pre-cancerous lesions develop in the anal canal.

Read the rest.

Wednesday, August 25, 2010

Study: Cream Helps Clear High-Grade Anal Lesions

via AIDSmeds

Long-term treatment with a topical immune-stimulating cream called Aldara (imiquimod), approved for the treatment of external genital warts, may also improve or clear high-grade lesions inside the anuses of men living with HIV and may potentially reduce the risk of cancer. This is the conclusion of a study published online August 19 in the journal AIDS.

Read the rest.

Friday, June 18, 2010

Pre-cancerous cell changes sometimes 'hidden' in anal warts of gay men




via Aidsmap, by Michael Carter

Cancerous or “high-grade” pre-cancerous cells changes were detected in a high proportion of anal warts surgically removed from gay men, US investigators report in the July 1st edition of Clinical Infectious Diseases.

The investigators believe that their findings could have implications for the management of anal warts.

There are two types of human papilloma virus (HPV) that can infect the anogenital tract. Strains of the virus that cause cauliflower-like anogential warts involve a low risk of anal cancer. However, some strains of the virus, especially HPV 16 and 18, can cause anal cancer and its precursor, the pre-cancerous cell changes called high-grade anal intraepithelial neoplasia (AIN).

Investigators wished to see if there was evidence of occult – or hidden – anal cancer or pre-cancerous cell changes in the anal warts which were surgically removed from 320 gay men, 50% of whom were HIV-positive. 

Read the rest. 

Wednesday, March 10, 2010

The unkindest cut of all for the gays (ineffective too)

Circumcision may not cut HIV spread among gay men

via Reuters

Although studies in Africa have shown that circumcision can lower the spread of HIV among heterosexuals, it may not do much to prevent infections among gay and bisexual men in Western countries, a new study suggests.

A number of studies in African nations have found that circumcised heterosexual men were up to 60 percent less likely than uncircumcised men to contract HIV during the study periods.

But it is unclear whether circumcision could have an impact on HIV transmission in the U.S. or other Western countries, where much of the transmission is among men who have sex with men. There has so far been no good evidence that circumcision lowers HIV risk among these men.

In the new study, researchers at the U.S. Centers for Disease Control and Prevention (CDC) looked at HIV infection rates among nearly 4,900 men in the U.S., Canada and the Netherlands who took part in a clinical trial of an HIV vaccine.

They found that circumcised and uncircumcised men showed no difference in the risk of HIV infection over three years.

Moreover, while having unprotected sex with an HIV-positive partner increased a man's risk of infection, there was no evidence that circumcision altered that risk.

Read the rest.

Monday, December 7, 2009

HIV-positive men at high risk for anal cancer - not all of us aware


Cancer researchers have found that since the introduction of highly active antiretroviral therapy HIV-positive men’s chances of having human papillomavirus (HPV) related anal cancers have increased. Yet many are not only unaware of their heightened risk but also do not know to seek HPV screening.

The lack of attention paid to HPV infections among HIVers has led to an incidence rate of anal cancer among HIV-positive men that now exceeds the highest incidence of cervical cancer among women reported anywhere in the world, recent studies have found.

"The incidence of human papillomavirus-associated anal cancer is unacceptably high among HIV-positive men who have sex with men, and possibly in HIV-positive women. Unlike most other malignancies occurring in the HIV-positive population, anal cancer is potentially preventable, using methods similar to those used to prevent cervical cancer in women," wrote Dr. Joel M. Palefsky, the co-leader of the cancer and immunity program at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, in an article this year in the medical journal Current Opinion in Oncology. "The high incidence of anal cancer among HIV-positive individuals must not be ignored, since it may be preventable."



Thursday, October 29, 2009

Confusion surrounds HPV vaccine for men

Among HIV-negative gay men, the rate of anal cancer is "as high as cervical cancer in women before the introduction of Pap smears. And if you are HIV-positive, it's about double that," Chin-Hong said. 
via Bay Area Reporter, by Bob Roehr

Should men routinely receive the vaccine for human papillomavirus (HPV) that protects against cervical and anal cancers and warts? Those hoping for a clear answer will have to settle for something less, at least for now.

The federal Food and Drug Administration approved Gardasil for use in women in 2006 to protect against four types of HPV that cause the vast majority of cancers and warts. It waited for completion of a trial in gay men to give the nod for that indication on October 16 of this year.

But a week later, on October 23, a Centers for Disease Control and Prevention advisory committee said Gardasil should not be added to the recommended list of vaccines for all pre-teens. That is important because the vaccine is most effective if it is given before one becomes sexually active.

Read the rest.

Related: Despite Approval, Evident Roadblocks to HPV Vaccine for Males Continue



Tuesday, October 20, 2009

Boys' Use Of Gardasil Is Approved


[Good news. But.... how VERY annoying that not a word is said in this story about the need of Gardasil for men in terms of gay men's health. The frame here is only around the male role in protecting women from cervical cancer. HELLO! How about protecting gay men from anal cancer???  It's not just a Farrah thing. The lives of gay men, and gay boys, COUNT, dammit.]
via the Wall Street Journal

The vaccine Gardasil won regulators' approval for use in males, setting the stage for a debate over whether boys should routinely receive an inoculation used to prevent cervical cancer in women.

The Food and Drug Administration found Gardasil, which has been approved for use in females since 2006, to be safe and effective in protecting males from genital warts. Now, the Centers for Disease Control and Prevention must decide whether to recommend its routine use in boys, a move that could lead states to mandate inoculation and may prompt health insurers to pay for it. A panel of experts advising the CDC is scheduled to debate the matter next week.

The question isn't straightforward, doctors and infectious-disease experts say, because boys may not directly benefit from being inoculated. Only about 1% of sexually active males in the U.S. develop genital warts, which can be irritating but aren't life-threatening, but males' vaccinations could help women because the sexually transmitted human papillomavirus (HPV) that causes the warts can lead to cervical cancer.


Read the rest.

Related:
Anal cancer prevention: how we are failing men who have sex with men 

Thursday, September 10, 2009

Hearing on HPV Vaccine for Boys: Public Comments Welcome



via POZ

Should the federal government pay for the Gardasil HPV vaccine for boys and young men covered by government-funded health programs? The Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) is holding a public hearing October 21 and 22 in Atlanta to discuss this important question and would like to hear from concerned community members, both in person and in writing.

Gardasil was approved in 2006 to help protect young women from the strains of human papilloma virus (HPV) that are most likely to cause cervical cancer and genital warts. Current guidelines recommend treating girls before they become sexually active, because a majority of women become infected with HPV within a short time after sexually activity has commenced.

The Food and Drug Administration (FDA) is now poised to approve the same vaccine to protect men from the same HPV strains that cause anal and penile warts and cancer. The FDA is expected to approve the vaccine’s use in preteen and teenage boys who have not yet become sexually active.

FDA approval is more scientific than political. The same is not true, however, when it comes to government decisions to pay for certain components of medical care. When ACIP recommended that government funds be used to vaccinate girls and young women, conservative activists objected strongly, claiming that the vaccine promoted promiscuity.

HIV and gay men’s health activists anticipate similar controversy at the ACIP hearing to determine whether the government should pay for the vaccine to protect men.

The mobilization of HIV and gay health activists is due, in part, to the fact that men who have sex with men have the highest rates of HPV infection and are likely to need the vaccine the most. Conservative groups are also expected to advocate against the government recommending payment for the vaccine, suggesting that it will promote both promiscuity and homosexuality.

Information about the ACIP hearing, which is open to the public, can be found on the CDC website. Written comments can also be submitted to the ACIP by e-mail at acip@cdc.gov.

Tuesday, July 28, 2009

Give Gardasil to boys too, experts say


Source

Recent evidence shows the human papilloma virus (HPV), which causes cervical cancer in women, is poised to become one of the leading causes of oral cancer in men because of changing sexual behaviours.

The findings have reignited the debate over whether boys should be given the cervical cancer vaccine, Gardasil.

A visiting British virologist, Professor Margaret Stanley, says governments around the world need to examine the long-term economic and health benefits of immunising boys and young men.

The head of Microbiology and Infectious Diseases at Melbourne's Royal Women's Hospital, Professor Suzanne Garland, says Australia is leading the way in the rollout of the cervical cancer vaccine Gardasil, which immunises against HPV.

"We are in our third year of rolling out the vaccine and we are in the order in the school-based group, in the high 70s, whereas in many other countries, they have only got 30 per cent who have been vaccinated," she said.

But now the vaccination debate has switched genders.

There are growing calls from the medical community for boys and young men to also be vaccinated against HPV.

Advocates include one of Britain's top cervical cancer specialists, Professor Margaret Stanley from Cambridge University, who says a cervical cancer jab in the arms of boys would not just be for the sake of girls.

"These HPVs don't just cause cancer in women. They cause it in men as well. Cancer in the mouth, cancer in the anus and those cancers are very hard to treat," she said.

Read the rest.


Related Posts Plugin for WordPress, Blogger...

select key words

2007 National HIV Prevention Conference 2009 National LGBTI Health Summit 2011 LGBTI Health Summit 2012 Gay Men's Health Summit 2012 International AIDS Conference ACT Up AIDS AIDS Foundation of Chicago Africa BUTT Bisexual Bisexual Health Summit Brian Mustanski Center on Halsted Charles Stephens Chicago Chicago Black Gay Men's Caucus Chicago Task Force on LGBT Substance Use and Abuse Chris Bartlett Coaching with Jake Congress David Halperin David Munar Dr. James Holsinger Dr. Jesus Ramirez-Valles Dr. Rafael Diaz Dr. Ron Stall ENDA Ed Negron Eric Rofes FTM Feast of Fun Feel the love... Friday is for Faeries Gay Men's Health Summit 2010 HCV HIV HIV care HIV drugs HIV negative HIV positive HIV prevention HIV stigma HIV strategic plan HIV testing HIV/AIDS HPV Howard Brown Health Center IML IRMA Illinois International AIDS Conference Jim Pickett LGBT LGBT adoption LGBT culture LGBT health LGBT rights LGBT seniors LGBT youth LGBTI community LGBTI culture LGBTI health LGBTI rights LGBTI spirituality LGV Leon Liberman LifeLube LifeLube forum LifeLube poll LifeLube subscription Lorenzo Herrera y Lozano Lymphogranuloma Venereum MRSA MSM Monday Morning Perk-Up National AIDS Strategy National Gay Men's Health Summit One Fey's Tale Peter Pointers Pistol Pete PnP PrEP President Barack Obama Presidential Campaign Project CRYSP Radical Faerie STD Senator Barack Obama Sister Glo Sisters of Perpetual Indulgence Susan Kingston Swiss declaration Ted Kerr Test Positive Aware Network The "Work-In" The 2009 Gay Men's Health Agenda Tony Valenzuela Trans Gynecology Access Program Trans and Intersex Association Trevor Hoppe Who's That Queer Woof Wednesday You Tube abstinence only activism advocacy african-american aging issues anal cancer anal carcinoma anal health anal sex andrew's anus athlete ball scene bareback porn barebacking bathhouses bears big bold and beautiful bisexuality black gay men black msm blood ban blood donor body image bottom chubby chaser circumcision civil rights civil union communication community organizing condoms crystal meth dating dating and mating with alan irgang depression disclosure discrimination domestic violence don't ask don't tell douche downlow drag queen emotional health exercise female condom fitness gay culture gay identity gay latino gay male sex gay marriage gay men gay men of color gay men's health gay pride gay rights gay rugby gay sex gay youth gender harm reduction hate crime health care health care reform health insurance hepatitis C hiv vaccine homophobia homosexuality hottie hotties how are you healthy? human rights humor hunk immigration international mr. leather internet intimacy leather community leathersex lifelube survey love lube lubricant masturbation mental health microbicides middle music negotiated safety nutrition oral sex physical health pleasure podcast policy politics poppers porn post-exposure prophylaxis prevention prostate prostate cancer public health public sex venues queer identity racism recovery rectal microbicides relationships religion research safe sex semen sero-adaptation sero-sorting seroguessing sex sexual abuse sexual addiction sexual health sexual orientation smoking social marketing spirituality stigma stonewall riots substance abuse treatment substance use suicide super-bug superinfection syphilis testicle self-examination testicular cancer testing top trans group blog transgender transgender day of remembrance transgendered transmen transphobia transsexual universal health care unsafe sex vaccines video violence viral load writers yoga youtube